Q2

INDOCO REMEDIES LTD.

INDOCOFY2606 Nov 2025

Revenue+10.7%

Net Profit+74.7%

OPM8.77%

P&L

Quarterly Consolidated

Revenue

+10.7%484.67

Expenditure

+4.7%498.43

Net Profit

+74.7%-9.21

NPM -1.90%+77.0%EPS ₹1.00-74.6%

vs Q1 FY26

Informational and educational content only. Not investment advice.